# Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

> **NCT00891527** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 50 (actual)

## Conditions studied

- Pulmonary Veno Occlusive Disease

## Interventions

- **DRUG:** Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)

## Key facts

- **NCT ID:** NCT00891527
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891527, "Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00891527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*